AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tacrofit 0.03% Ointment

Prescription Icon
Prescription Required

Marketer

Nri Vision Care India Limited

Salt Composition

Tacrolimus (0.03% w/w)

Overview Tacrofit 0.03% Ointment

Eczema (atopic dermatitis) is treated with Tacrofit 0.03% Ointment, which reduces inflammation (skin redness and swelling) by modulating the activity of specific immune cells. This soothes itching and improves atopic dermatitis rashes. Applied externally, Tacrofit 0.03% Ointment should be gently and evenly rubbed into affected skin 2-4 times daily, or as prescribed. Avoid overuse and occlusive dressings. Report any lack of improvement or worsening skin condition after a two-week trial to your physician. Potential side effects include redness, headache, folliculitis, and local reactions such as burning, irritation, itching, and redness. Unless medically necessary, this ointment is generally not recommended during pregnancy or lactation.

Uses of Tacrofit 0.03% Ointment

Managing atopic eczema

Major Benefits of Tacrofit 0.03% Ointment:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application guidelines. Ensure the affected skin is clean and dry before gently rubbing in the ointment.

Common Side effects of Tacrofit 0.03% Ointment:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Tacrofit 0.03% Ointment:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application guidelines. Ensure the affected skin is clean and dry before applying the ointment with a gentle massage.

How Tacrofit 0.03% Ointment works:

Immunosuppressant Tacrofit 0.03% Ointment reduces skin inflammation—the redness and swelling—by inhibiting overactive immune cells. This alleviates itching and improves the rash characteristic of atopic dermatitis.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Tacrofit 0.03% Ointment during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Topical Tacrolimus 0.03% ointment is likely compatible with breastfeeding. Available human data indicate minimal infant risk associated with its use.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No known drug interactions.

What if you forget to take Tacrofit 0.03% Ointment :

For a missed application of Tacrofit 0.03% Ointment, apply immediately. If your next scheduled application is imminent, omit the missed dose and resume your usual dosing regimen.

Facts to Know About Tacrofit 0.03% Ointment

LabelValue
Chemical Type Macrolide antibiotics
Developing Habits No.
Treatment Category Cancer Medications
Actions Calcineurin inhibitor immunosuppressants

FAQs on Tacrofit 0.03% Ointment

Tacrofit 0.03% Ointment is an immunosuppressant used to treat moderate to severe eczema (atopic dermatitis) in adults unresponsive to, or experiencing side effects from, steroid treatments. Atopic dermatitis involves an overactive skin immune system causing inflammation, itchiness, redness, and dryness. Tacrofit 0.03% Ointment modifies this abnormal immune response, reducing inflammation and itching.
Applying Tacrofit 0.03% Ointment may cause mild to moderate skin irritation, including burning, itching, redness, warmth, pain, altered sensation, and rash at the application site. These side effects usually subside within a week. Treatment also increases the risk of inflamed or infected hair follicles, cold sores, acne, and generalized herpes simplex infections.
Tacrofit 0.03% Ointment offers safe and effective short-term atopic dermatitis treatment, demonstrating superior safety compared to other immunosuppressants. Minimal systemic absorption following topical application results in fewer side effects than oral administration.
Tacrofit 0.03% Ointment is not a controlled substance because it lacks abuse potential. Controlled substances require authorization from both a doctor and relevant authorities due to their potential for misuse.
Prolonged use of Tacrofit 0.03% Ointment is associated with a heightened risk of lymphoma, a type of lymph node tumor. Studies indicate a link between Tacrofit 0.03% Ointment (or similar medications) and the development of skin cancer or lymphoma in a small number of patients. If you need to use Tacrofit 0.03% Ointment for over six weeks, or if your eczema symptoms worsen or fail to improve, consult your physician.
Tacrofit 0.03% Ointment is a non-steroidal medication that modifies immune system function. It treats eczema, particularly atopic dermatitis, without the skin thinning or other side effects associated with steroids.
Tacrofit 0.03% Ointment
82
MRP 100
18% off